Ad
related to: prqr stock
Search results
Is ProQR (PRQR) Stock a Solid Choice Right Now?
Zacks via Yahoo Finance· 6 months agoOne stock that might be an intriguing choice for investors right now is ProQR Therapeutics N.V. PRQR. This is because this security in the Medical -...
ProQR (PRQR) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoProQR (PRQR) delivered earnings and revenue surprises of -47.83% and 7.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues...
ProQR Therapeutics' (NASDAQ:PRQR) investors will be pleased with their impressive 109% return over...
Simply Wall St. via Yahoo Finance· 12 months agoProQR Therapeutics N.V. (NASDAQ:PRQR) shareholders might understandably be very concerned that the...
ProQR Therapeutics (NASDAQ:PRQR) shareholders have endured a 83% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 1 year agoProQR Therapeutics N.V. (NASDAQ:PRQR) shareholders will doubtless be very grateful to see the share...
Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago
Simply Wall St. via Yahoo Finance· 1 month agoLong term investing works well, but it doesn't always work for each individual stock. We don't wish...
Individual investors account for 45% of ProQR Therapeutics N.V.'s (NASDAQ:PRQR) ownership, while...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of ProQR Therapeutics N.V. (NASDAQ:PRQR), it is important...
Will ProQR (PRQR) Report Negative Q1 Earnings? What You Should Know
Zacks via Yahoo Finance· 1 year agoProQR (PRQR) doesn't possess the right combination of the two key ingredients for a likely earnings...
ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are retail investors with 50% stake, while 31% is...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights The considerable ownership by retail investors in ProQR Therapeutics indicates that...
While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12%...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significant control over ProQR Therapeutics by individual investors implies that the...
Biotech Stock Roundup: GILD's HIV Drug Approval, PRQR Surges on LLY Deal & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with many important pipeline and regulatory updates. Collaboration...
